Additionally, epigenetic therapies for cancer including DNA methyltransferase inhibitors (DNMTi), histone deacetylase inhibitors (HDACi), and histone methyltransferase inhibitors (HMTi) can stimulate antitumor immunity in host immune effector cells. The gene discussed is PRDM9; the disease is cancer.